Eco Animal Health Group Plc (EAH)
London Exchange · UK · prices in GBX · close of 20 Oct 2026
Key indicators
| Last close | GBX 95.50 |
|---|---|
| 52-week range | 80.01 – 116.90 |
| Return, 1 month / 3 months | −0.5% / +8.5% |
| Return, 1 year / 3 years | +14.4% / −9.9% |
| Trend | Below its 200-day average |
| RSI (14) | 46 |
| Volatility (1 year) | 35.9% |
| Worst drawdown (1 year) | -24.6% |
| Average daily value traded | 18.94M GBX |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Eco Animal Health Group develops and supplies veterinary medicines and vaccines for livestock, with a focus on pigs and poultry. Its product range includes antimicrobial treatments and vaccines used by farmers and animal health companies to manage disease in herds and flocks. The company is based in the United Kingdom and serves customers in many countries through its own operations and distribution partners, working with livestock producers and veterinary professionals.
The shares are listed on the London Exchange in UK under the code EAH, and the price on this page is in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Eco Animal Health Group Plc (EAH) trades on the London Exchange in UK. It last closed at GBX 95.50 on 20 October 2026.
Its price-based Market X-Ray is 59 out of 100 (a fair price profile), ranking 1,418 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 14.4% and over the last three months it rose 8.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 46 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -2.4% | ||
| From 52-week high | -16.2% | ||
| Momentum | 64 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 8.5% | ||
| 6-month return | 2.1% | ||
| 12-month return, skipping the last month | 15.0% | ||
| Stability (higher is calmer) | 55 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 35.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -24.6% | ||
| Liquidity | 78 · Strong | Trades actively. | |
| Average daily value traded | 18.94M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | −0.5% |
| 3 months | +8.5% |
| 6 months | +2.1% |
| 1 year | +14.4% |
| 3 years | −9.9% |
| 5 years | −66.5% |
Signals
| 50-day / 200-day average | 97.89 / 97.85 |
|---|---|
| Golden / death cross (60 days) | Golden, 13 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.62 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 23 Sep 2021 | GBP 0.0100 |
| 26 Sep 2019 | GBP 0.1104 |
| 28 Feb 2019 | GBP 0.0400 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.